Catalyst Wire Dossier Catalyst Wire Dossier

Meticel Ofteno 0.5%

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Meticel Ofteno 0.5%, covering 2025-02-14 to 2026-04-08. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Manzanilla® and Meticel Ofteno® 0.5% for Providing a Relief Sensation to the Eyes [Phase 4]

See pricing